Insulin therapy is required for the treatment of type 1 diabetes. Successful continuous subcutaneous insulin infusion therapy requires appropriate candidate selection, ongoing support and frequent involvement with the healthcare team.Ĭontinuous glucose monitoring may be offered to people not meeting their glycemic targets, who will wear the devices the majority of the time, in order to improve glycemic control. If glycemic targets are not met with optimized multiple daily injections, continuous subcutaneous insulin infusion may be considered. Avoidance of nocturnal hypoglycemia may include changes in insulin therapy and increased monitoring. Insulin regimens should be tailored to the individual's treatment goals, lifestyle, diet, age, general health, motivation, hypoglycemia awareness status and ability for self-management.Īll individuals with type 1 diabetes should be counselled about the risk, prevention and treatment of hypoglycemia. multiple daily injections or continuous subcutaneous insulin infusion) are the preferred insulin management regimens for adults with type 1 diabetes.
